SCHEMBL7704073

SCHEMBL7704073

Cc1cc(C(F)(F)F)ncn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.56
CHKA P35790 1/20 0.56
HSP90AA1 P07900 1/20 0.47
HSP90AB1 P08238 1/20 0.47
THRB P10828 1/20 0.41
LOXL2 Q9Y4K0 2/20 0.35
LOX P28300 1/20 0.34
KDM4E B2RXH2 5/20 0.34
KMT2A Q03164 3/20 0.34
HSD17B10 Q99714 3/20 0.34
MEN1 O00255 2/20 0.34
HTT P42858 1/20 0.34
ATM Q13315 1/20 0.34
AR P10275 1/20 0.33
TRPV4 Q9HBA0 1/20 0.32
SCN9A Q15858 1/20 0.32
LMNA P02545 1/20 0.32
KCNT1 Q5JUK3 1/20 0.32
MAP4K4 O95819 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17816462 0.86 CA2 (0.40) CA2CHKAHSP90AA1HSP90AB1THRB
SCHEMBL17816467 0.84 CA2 (0.39) CA2CHKAHSP90AA1HSP90AB1THRB
SCHEMBL31691999 0.84 CA2 (0.39) CA2CHKAHSP90AA1HSP90AB1THRB
SCHEMBL20320381 0.82 CA2 (0.38) CA2CHKAHSP90AA1HSP90AB1THRB
SCHEMBL27264896 0.82 CA2 (0.68) CA2CHKAHSP90AA1HSP90AB1LOXL2
SCHEMBL84119 0.78 KDM4E (0.32) CA2CHKAHSP90AA1HSP90AB1THRB
SCHEMBL10197318 0.76 CA2 (0.56) CA2CHKAHSP90AA1HSP90AB1LOXL2
SCHEMBL30849517 0.76
SCHEMBL20320546 0.74 KDM4E (0.36) CA2CHKATHRBKDM4EUHRF1
SCHEMBL12859621 0.74 AAK1 (0.35) CA2CHKAHSP90AA1HSP90AB1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120004811-A Novel method for synthesizing 2-hydrazino-substituted pyrimidine 凯里学院 2025-05-16 CN disclosed
EP-4423090-A2 ANTAGONISTS OF GPR39 PROTEIN Vasocardea, Inc. (US) 2024-09-04 EP disclosed
US-20230309388-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-09-28 US disclosed
US-20230303522-A1 ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDAL AGENT CONTAINING THE COMPOUND, AND METHOD OF USE THEREOF NIHON NOHYAKU CO., LTD. (JP) 2023-09-28 US disclosed
US-20230309388-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-09-28 US disclosed
US-20230293519-A1 INTEGRIN INHIBITORS AND USES THEREOF IN COMBINATION WITH OTHER AGENTS PLIANT THERAPEUTICS INC (US) 2023-09-21 US disclosed
EP-3418280-B1 COMPOUNDS AS MODULATORS OF ROR GAMMA BOEHRINGER INGELHEIM INT (DE) 2023-07-12 EP disclosed
WO-2023076219-A2 ANTAGONISTS OF GPR39 PROTEIN VASOCARDEA, INC. (US) 2023-05-04 WO disclosed
EP-4174057-A1 ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDE COMPRISING SAID COMPOUND, AND METHOD FOR USING SAID INSECTICIDE Nihon Nohyaku Co., Ltd. (JP) 2023-05-03 EP disclosed
WO-2023064345-A1 SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF VANQUA BIO, INC. (US) 2023-04-20 WO disclosed
US-8822460-B2 Fused cyclopentyl antagonists of CCR2 JANSSEN PHARMACEUTICA NV (BE) 2014-09-02 US disclosed
US-20140155377-A1 3-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS INCYTE CORPORATION (US) 2014-06-05 US disclosed
US-20140018356-A1 FUSED CYCLOPENTYL ANTAGONISTS OF CCR2 JANSSEN PHARMACEUTICA, NV (BE) 2014-01-16 US disclosed
US-20130267513-A1 PYRAZOLOPYRIDINES AS INHIBITORS OF THE KINASE LRRK2 MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) 2013-10-10 US disclosed
US-20130197008-A1 3-AMINOCYCLOPENTANECARBOXAMIDES AS CHEMOKINE RECEPTOR AGONISTS PFIZER INC. (US) 2013-08-01 US disclosed
WO-2013064518-A1 PESTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2013-05-10 WO disclosed
WO-2011141756-A1 PYRAZOLOPYRIDINES AS INHIBITORS OF THE KINASE LRRK2 MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) 2011-11-17 WO disclosed
US-7402548-B2 Benzoxazole compounds, process for producing the same and herbicides KYOYU AGRI CO., LTD. (JP) 2008-07-22 US disclosed
US-7402548-B2 Benzoxazole compounds, process for producing the same and herbicides KYOYU AGRI CO., LTD. (JP) 2008-07-22 US disclosed
EP-1637525-B1 Benzoxazole compound, process for producing the same, and herbicides KYOYU AGRI CO LTD (JP) 2007-12-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130197008-A1 3-AMINOCYCLOPENTANECARBOXAMIDES AS CHEMOKINE RECEPTOR AGONISTS ACKR3, CCR2, CCR5 CA2 1429/4885CHKA 2154/4885HSP90AA1 3205/4885
US-20140155377-A1 3-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS CCR2, CCR5, CXCR3 CA2 3814/4885CHKA 1627/4885HSP90AA1 4341/4885
US-20230293519-A1 INTEGRIN INHIBITORS AND USES THEREOF IN COMBINATION WITH OTHER AGENTS ITGB6, ITGA5, ITGAV CA2 3868/4885CHKA 2972/4885HSP90AA1 2064/4885
US-20230303522-A1 ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF, INSECTICIDAL AGENT CONTAINING THE COMPOUND, AND METHOD OF USE THEREOF CYP4Z1, DDT, AADAC CA2 93/4885CHKA 3072/4885HSP90AA1 487/4885
US-20140018356-A1 FUSED CYCLOPENTYL ANTAGONISTS OF CCR2 CCR2, CCR5, CCR1 CA2 2421/4885CHKA 1812/4885HSP90AA1 3663/4885
US-20230309388-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE OCIAD1, OCIAD2, SLCO4C1 CA2 3579/4885CHKA 3715/4885HSP90AA1 4602/4885
US-20130267513-A1 PYRAZOLOPYRIDINES AS INHIBITORS OF THE KINASE LRRK2 LRRK2, PARK7, GRK3 CA2 4636/4885CHKA 175/4885HSP90AA1 4019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.